The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease
Open accessAbstract
Infection or sterile inflammation triggers site-specific attraction of leukocytes. Leukocyte recruitment is a process comprising several steps orchestrated by adhesion molecules, chemokines, cytokines and endogenous regulatory molecules. Distinct adhesive interactions between endothelial cells and leukocytes and signalling mechanisms contribute to the temporal and spatial fine-tuning of the leukocyte adhesion cascade. Central players in the leukocyte adhesion cascade include the leukocyte adhesion receptors of the β2-integrin family, such as the αLβ2 and αMβ2 integrins, or of the β1-integrin family, such as the α4β1- integrin. Given the central involvement of leukocyte recruitment in different inflammatory and autoimmune diseases, the leukocyte adhesion cascade in general, and leukocyte integrins in particular, represent key therapeutic targets. In this context, the present review focuses on the role of leukocyte integrins in the leukocyte adhesion cascade. Experimental evidence that has implicated leukocyte integrins as targets in animal models of inflammatory disorders, such as experimental autoimmune encephalomyelitis, psoriasis, inflammatory bone loss and inflammatory bowel disease as well as preclinical and clinical therapeutic applications of antibodies that target leukocyte integrins in various inflammatory disorders are presented. Finally, we review recent findings on endogenous inhibitors that modify leukocyte integrin function, which could emerge as promising therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–254 of 254
Stadtmann, A., Brinkhaus, L., Mueller, H., Rossaint, J., Bolomini‐Vittori, M., Bergmeier, W., Aken, H. V., Wagner, D. D., Laudanna, C., Ley, K. F., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041196 · Cited by 94
Manifestations of Inflammatory Arthritis Are Critically Dependent on LFA-1
Watts, G. M., Beurskens, F. J. M., Martín-Padura, I., Ballantyne, C. M., Klickstein, L. B., Brenner, M. B., & Lee, D. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3668 · Cited by 93
Ludviksson, B. R., Strober, W., Nishikomori, R., Hasan, S. K., & Ehrhardt, R. O. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4975 · Cited by 93
Chavakis, T., May, A. E., Preissner, K. T., & Kanse, S. M. (1999) · Blood · doi:10.1182/blood.v93.9.2976 · Cited by 91
Self-citationJain, P., Coisne, C., Enzmann, G. U., Rottapel, R. K., & Engelhardt, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901404 · Cited by 89
Mace, E. M., Zhang, J., Siminovitch, K. A., & Takei, F. (2010) · Blood · doi:10.1182/blood-2009-12-261487 · Cited by 89
Choi, E. Y., Lim, J.-H., Neuwirth, A., Economopoulou, M., Chatzigeorgiou, A., Chung, K.-J., Bittner, S., Lee, S.-H., Langer, H. F., Samus, M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.146 · Cited by 88
Self-citationCutting Edge: Loss of α4 Integrin Expression Differentially Affects the Homing of Th1 and Th17 Cells
Glatigny, S., Duhen, R., Oukka, M., & Bettelli, E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102515 · Cited by 87
Ludviksson, B. R., Strober, W., Nishikomori, R., et al. (1999) · PubMed · Cited by 86
Gene from a Psoriasis Susceptibility Locus Primes the Skin for Inflammation
Wolf, R., Mascia, F., Dharamsi, A., Howard, O. M. Z., Cataisson, C., Bliskovski, V., Winston, J., Feigenbaum, L., Lichti, U. F., Ruzicka, T., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001108 · Cited by 86
Self-citationAlon, R., & Feigelson, S. W. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.06.001 · Cited by 85
Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment
Chavakis, T., Athanasopoulos, A. N., Rhee, J.-S., Orlova, V. V., Schmidt-Wöll, T., Bierhaus, A., May, A. E., Çeli̇k, İ., Nawroth, P. P., & Preissner, K. T. (2004) · Blood · doi:10.1182/blood-2004-01-0166 · Cited by 83
Self-citationLaschinger, M., Vajkoczy, P., & Engelhardt, B. (2002) · European Journal of Immunology · Cited by 82
CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis
Bixel, M. G., Li, H., Petri, B., Khandoga, A. G., Khandoga, A., Zarbock, A., Wolburg‐Buchholz, K., Wolburg, H., Sorokin, L. M., Zeuschner, D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-256388 · Cited by 81
Dedrick, R. L., Walicke, P. A., & Garovoy, M. R. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00029-1 · Cited by 80
Chamian, F., & Krueger, J. G. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000129715.35024.50 · Cited by 76
Activated Integrin VLA-4 Localizes to the Lamellipodia and Mediates T Cell Migration on VCAM-1
Hyun, Y., Chung, H.-L., McGrath, J. L., Waugh, R. E., & Kim, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803388 · Cited by 74
Inforzato, A., Reading, P. C., Barbati, E., Bottazzi, B., Garlanda, C., & Mantovani, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00407 · Cited by 74
Barck, K. H., Lee, W. P., Diehl, L. J., Ross, J., Gribling, P., Zhang, Y., Nguyen, K., van Bruggen, N., Hurst, S., & Carano, R. A. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20557 · Cited by 74
Willenborg, D. O., Simmons, R. D., Tamatani, T., & Miyasaka, M. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90175-x · Cited by 72
Singh, K., Gatzka, M., Peters, T., Borkner, L., Hainzl, A., Wang, H., Sindrilaru, A., & Scharffetter‐Kochanek, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202399 · Cited by 70
Peters, M. A., Wendholt, D., Strietholt, S., Frank, S., Pundt, N., Korb‐Pap, A., Joosten, L. A. B., van den Berg, W. B., Kollias, G. A., Eckes, B., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33487 · Cited by 69
Sheremata, W. A., Minagar, A., Alexander, J. S., & Vollmer, T. L. (2005) · CNS Drugs · doi:10.2165/00023210-200519110-00002 · Cited by 66
Kebir, D. E., József, L., & Filep, J. G. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107765 · Cited by 66
The annexin 1 receptor(s): is the plot unravelling?
Perretti, M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.010 · Cited by 63
Discoidin domain of Del1 protein contributes to its deposition in the extracellular matrix
Hidai, C., Kawana, M., Kitano, H., & Kokubun, S. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0456-9 · Cited by 62
Regulation of LFA-1–dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins
Choi, E. Y., Orlova, V. V., Fagerholm, S. C., Nurmi, S. M., Zhang, L., Ballantyne, C. M., Gahmberg, C. G., & Chavakis, T. (2008) · Blood · doi:10.1182/blood-2007-07-103077 · Cited by 58
Self-citationRegulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen
Chavakis, T., Kanse, S. M., Pixley, R. A., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0201com · Cited by 56
Self-citationMitroulis, I., Kang, Y., Gahmberg, C. G., Siegert, G., Hajishengallis, G., Chavakis, T., & Choi, E. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-09-0794 · Cited by 53
Self-citationSydora, B. C., Wagner, N., Löhler, J., Yakoub, G., Kronenberg, M., Müller, W., & Aranda, R. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01892.x · Cited by 52
Kanczkowski, W., Chatzigeorgiou, A., Großklaus, S., Sprott, D., Bornstein, S. R., & Chavakis, T. (2013) · Endocrinology · doi:10.1210/en.2012-1617 · Cited by 51
Self-citationBullard, D. C., Hu, X., Adams, J. E., Schoeb, T. R., & Barnum, S. R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061016 · Cited by 50
Xie, C., Alcaide, P., Geisbrecht, B. V., Schneider, D., Herrmann, M., Preissner, K. T., Luscinskas, F. W., & Chavakis, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051681 · Cited by 49
Self-citationLeon, F., Contractor, N., Fuss, I. J., Marth, T., Lahey, E., Iwaki, S., la Sala, A., Hoffmann, V. J., Strober, W., & Kelsall, B. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6974 · Cited by 48
Zeigler, M. E., Chi, Y., Tumas, D. B., Bodary, S. C., Tang, H., & Varani, J. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780339 · Cited by 47
Leukocyte Traffic Blockade as a Therapeutic Strategy in Inflammatory Bowel Disease
Bamias, G., Clark, D. L., & Rivera–Nieves, J. (2013) · Current Drug Targets · doi:10.2174/13894501113149990158 · Cited by 46
The role of junctional adhesion molecules in cell-cell interactions.
Keiper, T., Santoso, S., Nawroth, P. P., Orlova, V. V., & Chavakis, T. (2005) · Histology and histopathology · doi:10.14670/hh-20.197 · Cited by 45
Self-citationChung, K., Mitroulis, I., Wiessner, J. R., Zheng, Y. Y., Siegert, G., Sperandio, M., & Chavakis, T. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0867 · Cited by 45
Self-citationShin, J., Hosur, K. B., Pyaram, K., Jotwani, R., Liang, S., Chavakis, T., & Hajishengallis, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/617809 · Cited by 45
Self-citationIntegrin αEβ7: Molecular Features and Functional Significance in the Immune System
Hadley, G. A., & Higgins, J. M. G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9153-3_7 · Cited by 43
Wang, Y., Kai, H., Chang, F., Shibata, K., Tahara‐Hanaoka, S., Honda, S.-I., Shibuya, A., & Shibuya, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.104 · Cited by 43
Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof
Chavakis, T. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02677.x · Cited by 42
Self-citationDöring, A., Pfeiffer, F., Meier, M., Dehouck, B., Tauber, S., Deutsch, U., & Engelhardt, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201040912 · Cited by 39
Partial inhibition of AT-EAE by an antibody to ICAM-1: Clinico-histological and MRI studies
Morrissey, S., Deichmann, R., Syha, J., Simonis, C., Zettl, U. K., Archelos, J. J., Jung, S., Stodal, H., Lassmann, H., Toyka, K. V., et al. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00064-1 · Cited by 37
Villablanca, E. J., Calisto, J. D., Paredes, P. T., Cassani, B., Nguyen, D. D., Gabrielsson, S., & Mora, J. R. (2013) · Gut · doi:10.1136/gutjnl-2013-305386 · Cited by 37
Gültner, S., Kuhlmann, T., Hesse, A., Weber, J. P., Riemer, C., Baier, M., & Hutloff, A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040576 · Cited by 36
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis
Viguier, M. A., Richette, P., Aubin, F., Beylot-Barry, M., Lahfa, M., Bédane, C., Delesalle, F., Richard, M. A., Delaporte, E., Dubertret, L., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23507 · Cited by 36
Kang, Y., Kim, D., Lee, S. H., & Choi, E. Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.009 · Cited by 33
Dugger, K. J., Zinn, K. R., Weaver, C. T., Bullard, D. C., & Barnum, S. R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.10.006 · Cited by 33
Ostanin, D. V., Furr, K. L., Pavlick, K. P., Gray, L. T., Kevil, C. G., Shukla, D., D’Souza, D., Hoffman, J. M., & Grisham, M. B. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00573.2006 · Cited by 30
β7 Integrin Deficiency Suppresses B Cell Homing and Attenuates Chronic Ileitis in SAMP1/YitFc Mice
Gorfu, G., Rivera–Nieves, J., Hoang, S. B., Abbott, D. W., Arbenz‐Smith, K., Azar, D., Pizarro, T. T., Cominelli, F., MCDUFFIE, M. J., & Ley, K. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903938 · Cited by 27
CD18 in Monogenic and Polygenic Inflammatory Processes of the Skin
Peters, T., Sindrilaru, A., Wang, H., Oreshkova, T., Renkl, A. C., Keß, D., & Scharffetter‐Kochanek, K. (2006) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsymp.5650006 · Cited by 22
Gatzka, M., Hainzl, A., Peters, T., Singh, K., Tasdogan, A., Wlaschek, M., & Scharffetter‐Kochanek, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300976 · Cited by 20
New‐onset, debilitating arthritis in psoriasis patients receiving efalizumab
Myers, W. A., Najarian, D. J., & Gottlieb, A. B. (2006) · Journal of Dermatological Treatment · doi:10.1080/09546630600967406 · Cited by 15
Cited by
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Kong, D.-H., Kim, Y., Kim, M., Jang, J., & Lee, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041057 · Cited by 683
Neutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
Emerging therapeutic opportunities for integrin inhibitors
Slack, R. J., Macdonald, S. J. F., Roper, J. A., Jenkins, R. G., & Hatley, R. J. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00284-4 · Cited by 540
The pathogenic role of angiogenesis in rheumatoid arthritis
Elshabrawy, H. A., Chen, Z., Volin, M. V., Ravella, S., Virupannavar, S., & Shahrara, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9477-2 · Cited by 533
Metadata
- Authors
- Mitroulis, I., Alexaki, V. I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., & Chavakis, T.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 147
- Pages
- 123-135
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2083311984
- Cited by
- 283
- References
- 254
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.